Work

489 Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation, in Patients With Narcolepsy: REST-ON Primary Results

Year: 2021

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsab072.488

Authors: Clete Kushida, Colin Shapiro, Thomas Roth, Michael Thorpy, Russell Rosenberg, Bruce Corser, Akinyemi Ajayi, Jordan Dubow, David Seiden, Yves Dauvilliers

Institutions: Stanford Medicine, Henry Ford Hospital, Albert Einstein College of Medicine, NeuroTrials Research (United States), Sleep Management Institute, Hôpital Gui de Chauliac

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3159482753

Cites:

Cited by: 2

Related to: 10